NL-OMON54836
Recruiting
Phase 3
Allogeneic Stem Cell Transplantation (SCT) for children and adolescents with acute lymphoblastic Leukaemia (ALL) - ALL SCTped 2012 FORUM
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- cancer of the blood
- Sponsor
- St, Anna Kinderkrebsforschung
- Enrollment
- 35
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients with ALL (except for patients with mature B\-ALL) who fulfil the
- •following criteria:
- •Age at diagnosis \<\= 18 years or age at HSCT \<\= 21 years.
- •indication for allogeneic HSCT
- •complete remission (CR) before SCT
- •written consent of the parents (legal guardian) and, if necessary,
- •the minor patient via \*Informed Consent Form\*
- •no pregnancy
- •no secondary malignancy
- •no previous HSCT
Exclusion Criteria
- •Patients who do not fulfil the inclusion criteria
- •Non Hodgkin\-Lymphoma
- •The whole protocol or essential parts are declined either by patient
- •himself/herself or
- •the respective legal guardian
- •No consent is given for saving and propagation of anonymous medical data for
- •study reasons
- •Severe concomitant disease that does not allow treatment according to the
- •protocol at the investigator\*s discretion (e.g. malformation syndromes, cardiac
- •malformations, metabolic disorders)
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
Transplantation of CordIn, stem cells from donated umbilical cord blood that were grown in a laboratory to expand their number, in patients with a kind of genetic defect that results in abnormal structure of one of the globin chains of the hemoglobin moleculeHemoglobinopathiesMedDRA version: 18.0Level: LLTClassification code 10054658Term: ThalassemiaSystem Organ Class: 100000004850MedDRA version: 18.0Level: LLTClassification code 10040645Term: Sickle cell disease NOSSystem Organ Class: 100000004850Therapeutic area: Diseases [C] - Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]EUCTR2014-003572-23-FRGamida Cell Ltd15
Active, not recruiting
Not Applicable
Allogeneic Stem Cell Transplantation in Children and Adolesecents with Acute Lymphoblastic LeukaemiaEUCTR2012-003032-22-FISt. Anna Kinderkrebsforschung1,000
Active, not recruiting
Phase 1
CML-SCT -IBFM StudyAllogeneic stem cell transplantation for children and Adolescents with CML: Conditioning regimen, donor selection, supportive care and diagnostic procedures. - CML-SCTChildren and adolecents with chronic myeloid leukemia with indication for allogeneic stem cell transplantationMedDRA version: 14.0Level: LLTClassification code 10009700Term: CMLSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Therapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]EUCTR2008-000569-50-CZSt Anna Kinderkrebsforschung160
Completed
Phase 1
Allogeneic stem cell transplantation for relapsed/refractory aggressive lymphoma with conditioning regimen consisted of fludarabine, iv busulfan, and melphalan (single center prospective trial)JPRN-UMIN000013940Department of Hematology Toranomon Hospital12
Active, not recruiting
Phase 1
Stem Cell Transplantation and Maintenance Therapy with Thalidomide / DLI for patients with Multiple MyelomaEUCTR2007-004928-21-DEniversity Medical Center Hamburg-Eppendorf220